Update on Rifampin Resistance in the Legionellaceae
A recent article described rpoB mutations in 18 rifampinresistant variants of Legionella spp. (4) . One of these 18 strains, isolate 8749, an in vitro-generated high-level rifampin-resistant (MIC Ն 256 g/ml) variant of K26, a susceptible clinical Legionella bozemanii isolate, was shown to harbor no codon exchange in the cluster I rpoB 69-bp hot spot, the DNA region investigated.
Besides codon exchanges in cluster I (e.g., codon 507 to 533 in Escherichia coli), several mutations in at least three rpoB regions outside cluster I have been described to be associated with resistance to rifampin (1) . Base pair numbering is based on the published sequence of Legionella pneumophila (4) and the unfinished Legionella Genome Project of the Columbia Genome Center (contig LP.WG.044.06.111099). IUB code is used for mixed base sites. The PCR products were sequenced on both strands. The 5Ј region of rpoB (2), especially codon 159 (GTT, valine), was not changed. The only mutation detected (ATT to TAT) was located in cluster II, downstream of the cluster I hot spot. This mutation induces an isoleucine-to-tyrosine amino acid substitution at position 587 of the protein sequence. In the great majority of cluster II mutations described to be associated with rifampin resistance in other species, the corresponding codon is changed. Amino acid exchanges in different species observed in our laboratory or found in the literature are summarized in Fig. 1 . Also included is a cluster II isoleucineto-threonine exchange (ATC to ACC, I586T) newly observed in two (802-1 and 802-2) of three H. pylori DNA samples provided by Wang et al., formerly described as rifampin resistant but harboring wild-type sequence in clusters I and II (6). In the third H. pylori DNA sample (802-3) from that study, amino acid exchange V149F, corresponding to the V146F exchange in E. coli (2) and the V176F exchange in M. tuberculosis, could be observed.
In conclusion, no cluster I mutation was found in strain 8749 that could explain the high level rifamycin resistance (4). Here we show that the isolate harbors a mutation in cluster II (I587Y), inducing an amino acid substitution that is known to be associated with rifamycin resistance in other species. In all comparable cases, complete sequence analysis of the respective rpoB regions (Fig. 1) revealed mutations corresponding to the Rif-resistant phenotype of H. pylori and Legionella spp. and also M. tuberculosis in our laboratory. To our knowledge, mutations outside the cluster I rpoB hot spot in Legionellaceae have not been described so far. This is also the first description of I-to-Y and I-to-T substitutions in cluster II.
